The cleanest entry into preventive testing if you're in Europe. Curated panel of markers that map to clinical decisions, sensible price, recognisably German product polish.
What Aware is.
Aware is the German equivalent of Function Health: a direct-to-consumer subscription that delivers periodic blood draws and dashboards your results in an app. The product positioning is more conservative than Function's — fewer markers per draw, focused on the cardiometabolic + hormonal + inflammation set that actually drives preventive decisions, with German-language clinical context.
For someone in the EU who wants their first taste of structured preventive testing — without flying to a private clinic or assembling lab panels through their GP — Aware is the most credible "first step" product. The chair is at a partner Limbach / Bioscientia lab; the product is a thin layer of subscription, scheduling, and dashboards on top.
The experience.
Booking and pre-test instructions are clean. The phlebotomy chair is whichever partner lab Aware sends you to — typically MDI Limbach or Bioscientia, both clinically reliable. Results land in the app within 24–48 hours, with each marker contextualised against population reference ranges and (in some cases) "optimal" ranges drawn from preventive-medicine literature rather than the standard "in range / out of range" clinical cut-offs. That's a meaningful improvement over a regular doctor's lab printout.
Where Aware shines is in not overwhelming. Function Health's 100+ markers can produce 20 yellow flags per draw, most of which don't matter. Aware's curated 30–50-ish markers means fewer but sharper signals. For a first-time preventive testing user, that's the right product decision.
The catch — slow to ship.
The honest issue with Aware in 2026 is product velocity. SuperPower, Function Health, and even smaller players like Marek Diagnostics ship visible feature changes every quarter — new markers, deeper integrations, better insights. Aware's product surface has barely moved in two years. The same panel, the same dashboard, the same recommendations layer.
For an early-stage longevity testing market that's evolving monthly, "stable product" reads as "stagnant roadmap." Whether that's a funding choice, a strategic decision to stay narrow, or simple velocity issues is something I can't tell from the outside — but it does change the calculus for someone deciding between Aware and the US incumbents.
"Aware is barely offering the same stuff as two years ago, while Function and SuperPower expand monthly."
The other limitation is the same one Function suffers from: the recommendations layer is broad. "Your vitamin D is below optimal — consider supplementation" is a true sentence that nobody pays a subscription to read. The data quality is solid; the insight quality is generic.
Pros
- Curated panel — the markers that matter, without 100+ low-signal extras
- Sensible price point — entry-level access to preventive testing in Europe
- Partner-lab phlebotomy is clinically reliable (MDI Limbach / Bioscientia)
- App contextualises against optimal ranges, not just clinical cut-offs
- Right product for the "first time doing preventive testing" user
Cons
- Roadmap has barely moved in two years while US peers expand monthly
- Recommendations skew generic — "consider supplementation"-tier insights
- Limited differentiation if you already work with a preventive clinic
- No physician interpretation included by default
Who it's for.
Aware is the right answer if you're in the EU, you've never had a structured preventive panel, and you want to start without overcommitting time or budget. It is a clean on-ramp into seeing your own biomarkers laid out clearly.
It's not the right answer if you've already done two or three rounds of preventive testing with a clinician — at that point, you've out-grown Aware's curated layer and you want a deeper product (try YEARS) or one that integrates with your existing workflow.
Verdict · 3.8 / 5
Best EU entry point into preventive biomarker testing. Loses one full point for product stagnation in a fast-moving market and another half for generic insights. Still the answer if you're in Europe and Function Health isn't available — and the curated panel is genuinely a virtue, not a limitation, for new users.
Related reviews.
Reviewed by Niko Hems · Last updated